Maze Therapeutics
CA - South SFBiotechnology
Focus: Maze Therapeutics is a public biotech company focused on small molecules, gene therapy, antisense oligonucleotides, and biologics, with a primary focus on gene therapy for rare and complex diseases. Headquartered in South San Francisco, the company operates at a mid-cap biotech scale with early-stage clinical programs.
Profile data last refreshed 22m ago · AI intelligence enriched 2mo ago
Total Funding
$115M
Open Jobs
15+4 this month
Stable — net +4 jobs in 30d
8 added, 4 removed. Backfill posture.
Should You Work at Maze Therapeutics?
AI assessmentMaze is a lean, gene-therapy-focused public biotech suitable for specialists willing to accept early-stage development risk in exchange for focused science and equity upside.
Why Work Here
- Active pipeline with Phase 2 program (MZE829) in proteinuric kidney disease, providing near-term clinical development visibility
- Public company status (NASDAQ listed) offers equity upside and long-term career stability vs. private biotech
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MZE001
HealthyClinical Trials (1)
NCT05249621A Randomized Phase 1 of of MZE001 in Healthy Volunteers
Phase 1Help build intelligence for Maze Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.